They have also shared their outlook on pharmaceuticals, telecom, healthcare, metals and banking, alongside broader commentary on India’s growth outlook, GDP trajectory and the evolving earnings cycle.
The successful passage of the bill could hurt India’s interests the most, as it is yet to sign a trade deal with the US.